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TreatmentIntroduction: Nontuberculous mycobacteria (NTM) are ubiquitous in the environment and
exist as important causes of pulmonary infections in human. Pulmonary involvement is
the most common disease manifestation of NTM and the incidence of NTM is growing in
the North America. Susceptibility to NTM infection is incompletely understood and,
therefore preventative tools are not well defined. Treatment of pulmonary nontuberculous
mycobacterial (NTM) infection is difficult and entails multiple antibiotics and an extended
treatment course. Also, there is a considerable variation in treatment management that
should be considered before initiating treatment.
Material and methods: A literature search was conducted using search keywords
‘‘nontuberculous mycobacteria,’’ ‘‘MAC,’’ ‘‘M. abscessus,’’ ‘‘epidemiology,’’ ‘‘treatment,’’
‘‘North America,’’ ‘‘mortality,’’ ‘‘cystic fibrosis,’’ ‘‘transplantation,’’ ‘‘prevention,’’ and
‘‘diagnosis’’ from studies that have been published between the years 2009 and 2014.
PubMed, Cinahl, Scopus, Embase, and the Cochrane Library were searched. A total of 382
articles were reviewed from which 65 papers met our selection criteria. Titles of interest
were further reviewed by all authors. Reference lists of relevant studies were
hand-searched in order to identify other potentially relevant articles. Studies included in
this review met the following criteria: (i) study populations included patients with NTM;
(ii) articles were full reports, case reports or reviews; (iii) articles were in English and
published from the US based institutes; (iv) articles were published in peer-reviewed
journals.
Results: Nontuberculous mycobacteria (NTM) are an important cause of morbidity and
mortality, often in the form of progressive lung disease. Few reports are accessible on
NTM disease prevalence in the United States; however based on the recent data the
incidence and mortality rates of pulmonary NTM have been reported to be rising in North
America. We highlight the new findings in the epidemiology, diagnosis and treatment of
mycobacterial infections. We debate new advances regarding NTM infection in cysticiversity of
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epidemiologic model for NTM disease based on virulence–exposure–host factors.
Conclusion: It is critical that NTM is recognized as an important public health issue with
potentially significant consequences for affected patients. Finally, the applicability of the
virulence–exposure–host model in NTM disease should be investigated.
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